Suppr超能文献

植物源疟原虫抗原——约氏疟原虫裂殖子表面蛋白 1 的 19 kDa C 末端片段的生产、特性和免疫原性。

Production, characterisation and immunogenicity of a plant-made Plasmodium antigen--the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1.

机构信息

Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia.

出版信息

Appl Microbiol Biotechnol. 2012 Apr;94(1):151-61. doi: 10.1007/s00253-011-3772-7. Epub 2011 Dec 15.

Abstract

Development of a safe, effective and affordable malaria vaccine is central to global disease control efforts. One of the most highly regarded proteins for inclusion in an asexual blood stage subunit vaccine is the 19-kDa C-terminal fragment of merozoite surface protein 1 (MSP1(19)). As production of vaccine antigens in plants can potentially overcome cost and delivery hurdles, we set out to produce MSP1(19) in plants, characterise the protein and test its immunogenicity using a mouse model. Plasmodium yoelii MSP1(19) (PyMSP1(19)) was produced in Nicotiana benthamiana using the MagnICON® deconstructed TMV-based viral vector. PyMSP1(19) yield of at least 23% total soluble protein (TSP;3-4 mg/g Fwt) were achieved using a codon-optimised construct that was targeted to the apoplast. Freeze-dried leaf powder contained at least 20 mg PyMSP1(19) per gram dry weight and the protein retained immunogenicity in this form for more than 2 years. Characterisation studies, including SDS-PAGE, mass spectrometry and circular dichroism, indicated that the plant-expressed PyMSP1(19) was similar to its Escherichia coli- and Saccharomyces cerevisiae-expressed counterparts. Purified plant-made PyMSP1(19) induced strong immune responses following intraperitoneal immunisation, although titres were lower than those induced by an equivalent dose of purified E. coli-expressed PyMSP1(19). The reason for this is uncertain but may be due to differences in the oligomerisation profile of the vaccines. The plant-made PyMSP1(19) vaccine was also found to be orally immunogenic when delivered alone or following immunisation with a PyMSP1(19) DNA vaccine. This study adds to an increasing body of research supporting the feasibility of plants as both a factory for the production of malaria antigens, and as a safe and affordable platform for oral delivery of a temperature-stable malaria vaccine.

摘要

开发安全、有效和负担得起的疟疾疫苗是全球疾病控制工作的核心。最受关注的纳入无性血阶段亚单位疫苗的蛋白质之一是裂殖子表面蛋白 1(MSP1(19))的 19kDa C 端片段。由于在植物中生产疫苗抗原有可能克服成本和输送障碍,我们着手在植物中生产 MSP1(19),对蛋白质进行表征,并使用小鼠模型测试其免疫原性。使用 MagnICON® 解构的基于 TMV 的病毒载体在 Nicotiana benthamiana 中生产 Plasmodium yoelii MSP1(19)(PyMSP1(19))。使用针对质外体的密码子优化构建体,至少可实现 23%总可溶性蛋白(TSP;3-4mg/g Fwt)的 PyMSP1(19)产量。冻干叶粉每克干重至少含有 20mg PyMSP1(19),并且该蛋白质在这种形式下至少 2 年保持免疫原性。包括 SDS-PAGE、质谱和圆二色性在内的表征研究表明,植物表达的 PyMSP1(19)与其大肠杆菌和酿酒酵母表达的对应物相似。纯化的植物制造的 PyMSP1(19)在腹腔内免疫后可诱导强烈的免疫反应,尽管效价低于等量纯化的大肠杆菌表达的 PyMSP1(19)诱导的效价。其原因尚不清楚,但可能是由于疫苗的寡聚化谱存在差异。当单独或在用 PyMSP1(19)DNA 疫苗免疫后口服给予时,还发现植物制造的 PyMSP1(19)疫苗具有口服免疫原性。这项研究增加了越来越多的研究支持植物作为疟疾抗原生产的工厂,以及作为温度稳定的疟疾疫苗口服给予的安全且负担得起的平台的可行性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验